The Gross Law Firm issues the following notice to shareholders of Dow Inc. (NYSE: DOW). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of DOW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Dow Inc. […]

The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SMLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Semler

The Gross Law Firm issues the following notice to shareholders ofSavara Inc. (NASDAQ: SVRA). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of SVRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/savara-inc-loss-submission-form/?id=173400&from=4 CLASS PERIOD: March

The Gross Law Firm issues the following notice to shareholders of V.F. Corporation (NYSE: VFC). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of VFC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: V.F. Corporation

The Gross Law Firm issues the following notice to shareholders ofaTyr Pharma, Inc. (NASDAQ: ATYR). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of ATYR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: aTyr Loss

The Gross Law Firm issues the following notice to shareholders ofBaxter International, Inc. (NYSE: BAX). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Baxter International,

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. https://mma.prnewswire.com/media/602982/ITUS_Corporation_Logo.jpg Mike Catelani, President and CFO of

Grant will help create a robust digital ecosystem designed to transform and scale menopause education and training worldwide The Menopause Society today announced a $5 million grant from the Steven & Alexandra Cohen Foundation, led by philanthropist and New YorkMets Owner Alex Cohen. The grant will support the digital-innovation phase of the NextGen Now initiative

Elkem ASA(ticker: ELK), a global leader in advanced silicon-based materials,today unveiled SILBIONE™ LSR Select EC 70, a next-generation medical-grade liquid silicone rubber. Designed for wearable and diagnostic devices, the material combines high electrical conductivity, certified biocompatibility1, and enhanced process control, setting a new standard for precision healthcare applications. https://mma.prnewswire.com/media/2803744/Electrical__1.jpg “SILBIONE™ LSR Select EC 70 marks

The Gross Law Firm issues the following notice to shareholders ofLifeMD, Inc. (NASDAQ: LFMD). https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE:https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=173396&from=4 CLASS PERIOD: May